Eli Lilly is set to invest $5 billion to construct a new manufacturing plant in Goochland, Virginia, aimed at boosting the production of targeted cancer drugs and other treatments. This investment will create approximately 2,450 permanent jobs in the region and is part of a broader initiative by the pharmaceutical company to expand its manufacturing capabilities across the United States. The facility is one of four new sites planned by Eli Lilly and comes as the company prepares for potential tariff impacts on the pharmaceutical industry.